Most potent GHRP available, with a corresponding desensitisation curve.
Typical dose range: 100 mcg
Frequency: 1–2 × daily, short cycles
Route: Subcutaneous
Half-life: ~1 h
Evidence level: Pre-clinical
Great for short blast phases. Not a daily long-term peptide due to receptor downregulation.